Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (597) clinical trials

NeuroTrials Research is conducting a 20-month, placebo-controlled research study evaluating an investigational drug for Alzheimer’s Disease. Study-related exams and study drug are provided at no cost. Qualified participants and caregivers will be compensated for time and travel. Patient Inclusion Criteria: Age 50-89 Diagnosis of probable Alzheimer’s Disease Must have a ...

Phase

Purpose of the study: This research seeks to understand how Down syndrome and Alzheimer’s disease may affect a person’s memory and thinking as they get older. The goals of this longitudinal project are: to follow neurological, learning and memory changes in adults with Down syndrome as they age; to examine ...

Phase N/A

This study is for participants that have been diagnosed with a mild to moderate form of Alzheimer's disease (AD). This research involves an experimental study drug known as LY2062430. The primary objective of this study is to test whether LY2062430 will slow the rate of mental (thinking and remembering) decline ...

Phase

Dr. Brian Goldman at Raleigh Medical Group is conducting a clinical research study for probable Alzheimer’s Disease patients of 50 years and older. Qualified participants will receive at no charge, study related physical exams, EKGs, lab work and study medication. They may be compensated for their time and travel. For ...

Phase N/A

Eligible participants for this study must have a diagnosis of probable AD and must have clinically meaningful agitation secondary to AD. This is a multicenter, randomized, placebo-controlled study, consisting of 12 weeks of treatment. Approximately 470 participants will be enrolled at approximately 75 centers in North America. Study medication will ...

Phase N/A

This is a multi-center, randomized, double-blind, placebo-controlled study, to assess the efficacy and safety of AXS-05 in the treatment of agitation in patients with Alzheimer's disease.

Phase N/A

The primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) score as compared with placebo in participants with early AD. Secondary objectives are to assess the ...

Phase N/A

The main purpose of this study is to evaluate the safety and the effect on brain tau of the study drug LY3202626 in participants with mild Alzheimer's disease (AD) dementia.

Phase N/A

A ten-week study to assess MP-101 in the treatment of psychosis in participants with Alzheimer's Disease, as compared to placebo.

Phase N/A

This study is a Phase 2, randomized, placebo controlled, dose ranging study of piromelatine (5, 20, and 50 mg daily for 6 months) versus placebo to determine an effective dose based on efficacy (cognitive performance), safety and tolerability in patients with mild dementia due to AD.

Phase N/A